The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Platelet-Rich Plasma: The Choice of Activation Method Affects the Release of Bioactive Molecules
Open accessAbstract
Platelet-Rich Plasma (PRP) is a low-cost procedure to deliver high concentrations of autologous growth factors (GFs). Platelet activation is a crucial step that might influence the availability of bioactive molecules and therefore tissue healing. Activation of PRP from ten voluntary healthy males was performed by adding 10% of CaCl 2, 10% of autologous thrombin, 10% of a mixture of CaCl 2+ thrombin, and 10% of collagen type I. Blood derivatives were incubated for 15 and 30 minutes and 1, 2, and 24 hours and samples were evaluated for the release of VEGF, TGF-β 1, PDGF-AB, IL-1 β, and TNF-α. PRP activated with CaCl 2, thrombin, and CaCl 2/thrombin formed clots detected from the 15-minute evaluation, whereas in collagen-type-I-activated samples no clot formation was noticed. Collagen type I produced an overall lower GF release. Thrombin, CaCl 2/thrombin, and collagen type I activated PRPs showed an immediate release of PDGF and TGF-β1that remained stable over time, whereas VEGF showed an increasing trend from 15 minutes up to 24 hours. CaCl 2 induced a progressive release of GFs from 15 minutes and increasing up to 24 hours. The method chosen to activate PRP influences both its physical form and the releasate in terms of GF amount and release kinetic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platelet-Rich Plasma: From Basic Science to Clinical Applications
Foster, T. E., Puskas, B. L., Mandelbaum, B. R., Gerhardt, M. B., & Rodeo, S. A. (2009) · The American Journal of Sports Medicine · doi:10.1177/0363546509349921 · Cited by 1,323
Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration
Weibrich, G., Hansen, T., Kleis, W., Buch, R., & Hitzler, W. E. (2004) · Bone · doi:10.1016/j.bone.2003.12.010 · Cited by 628
Platelet-Rich Plasma: The PAW Classification System
DeLong, J. M., Russell, R. P., & Mazzocca, A. D. (2012) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2012.04.148 · Cited by 623
Zhu, Y., Yuan, M., Meng, H. Y., Wang, A. Y., Guo, Q. Y., Wang, Y., & Peng, J. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.07.017 · Cited by 366
Optimization of Leukocyte Concentration in Platelet-Rich Plasma for the Treatment of Tendinopathy
McCarrel, T. M., Minas, T., & Fortier, L. A. (2012) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.l.00019 · Cited by 358
Lopez-Vidriero, E., Goulding, K. A., Simon, D. A., Sanchez, M., & Johnson, D. H. (2010) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1016/j.arthro.2009.11.015 · Cited by 314
Antimicrobial activity of platelet‐leukocyte gel against Staphylococcus aureus
Moojen, D. J. F., Everts, P. A. M., Schure, R., Overdevest, E. P., van Zundert, A., Knape, J. T. A., Castelein, R. M., Creemers, L. B., & Dhert, W. J. A. (2008) · Journal of Orthopaedic Research · doi:10.1002/jor.20519 · Cited by 298
Filardo, G., Kon, E., Roffi, A., Di Matteo, B., Merli, M. L., & Marcacci, M. (2015) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-013-2743-1 · Cited by 270
Self-citationPlatelet‐rich plasma (PRP) to treat sports injuries: evidence to support its use
Kon, E., Filardo, G., Di Martino, A., & Marcacci, M. (2011) · Knee Surgery, Sports Traumatology, Arthroscopy · doi:10.1007/s00167-010-1306-y · Cited by 253
Self-citationPlatelet Activation by Collagen Provides Sustained Release of Anabolic Cytokines
Harrison, S., Vavken, P., Kevy, S., Jacobson, M., Zurakowski, D., & Murray, M. M. (2011) · The American Journal of Sports Medicine · doi:10.1177/0363546511401576 · Cited by 221
Activation of Platelet-Rich Plasma Using Soluble Type I Collagen
Fufa, D., Shealy, B., Jacobson, M., Kevy, S., & Murray, M. M. (2008) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2007.06.635 · Cited by 180
Contents and Formulations of Platelet-Rich Plasma
Wasterlain, A. S., Braun, H. J., & Dragoo, J. L. (2012) · Operative Techniques in Orthopaedics · doi:10.1053/j.oto.2011.11.001 · Cited by 168
Platelet Gel (AGF) Fails to Increase Fusion Rates in Instrumented Posterolateral Fusions
Carreon, L. Y., Glassman, S. D., Anekstein, Y., & Puno, R. M. (2005) · Spine · doi:10.1097/01.brs.0000160846.85397.44 · Cited by 159
Han, B., Woodell‐May, J., Ponticiello, M. S., Yang, Z. G., & Nimni, M. E. (2009) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.h.00246 · Cited by 158
Martineau, I., Lacoste, E., & Gagnon, G. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.013 · Cited by 138
Bir, S. C., Esaki, J., Marui, A., Yamahara, K., Tsubota, H., Ikeda, T., & Sakata, R. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.06.016 · Cited by 132
Matteo, B. D., Filardo, G., Kon, E., & Marcacci, M. (2014) · MUSCULOSKELETAL SURGERY · doi:10.1007/s12306-014-0340-1 · Cited by 126
Self-citationFABBRO, M. D., Gallesio, G., & Mozzati, M. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.10.015 · Cited by 126
Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses
Torricelli, P., Fini, M., Filardo, G., Tschon, M., Pischedda, M., Pacorini, A., Kon, E., & Giardino, R. (2011) · International Orthopaedics · doi:10.1007/s00264-011-1237-3 · Cited by 120
Self-citationRanly, D. M., McMillan, J., Keller, T. A., Lohmann, C. H., Meunch, T., Cochran, D. L., Schwartz, Z., & Boyan, B. D. (2005) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200509000-00019 · Cited by 100
PRP Augmentation for ACL Reconstruction
Andriolo, L., Matteo, B. D., Kon, E., Filardo, G., Venieri, G., & Marcacci, M. (2015) · BioMed Research International · doi:10.1155/2015/371746 · Cited by 98
Self-citationARNOCZKY, S. P., Delos, D., & Rodeo, S. A. (2011) · Operative Techniques in Sports Medicine · doi:10.1053/j.otsm.2010.12.001 · Cited by 90
Platelet-rich plasma affects bacterial growth in vitro
Mariani, E., Filardo, G., Canella, V., Berlingeri, A., Bielli, A., Cattini, L., Landini, M. P., Kon, E., Marcacci, M., & Facchini, A. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.06.003 · Cited by 86
Self-citationPRP For the Treatment of Cartilage Pathology
Kon, E., Filardo, G., Matteo, B. D., & Marcacci, M. (2013) · The Open Orthopaedics Journal · doi:10.2174/1874325001307010120 · Cited by 76
Self-citationHamilton, B. H., Tol, J. L., Knez, W. L., & Chalabi, H. (2013) · British Journal of Sports Medicine · doi:10.1136/bjsports-2012-091916 · Cited by 70
Textor, J. A., Norris, J. W., & Tablin, F. (2011) · American Journal of Veterinary Research · doi:10.2460/ajvr.72.2.271 · Cited by 69
Cited by
Chen, X., Jones, I. A., Park, C., & Vangsness, C. T. (2018) · The American Journal of Sports Medicine · doi:10.1177/0363546517743746 · Cited by 294
Di Martino, A., Di Matteo, B., Papio, T., Tentoni, F., Selleri, F., Cenacchi, A., Kon, E., & Filardo, G. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546518814532 · Cited by 272
Self-citationThe potential of platelet-rich plasma injections and stem cell therapy for penile rejuvenation
Israeli, J. M., Lokeshwar, S. D., Efimenko, I. V., Masterson, T. A., & Ramasamy, R. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-021-00482-z · Cited by 30
“AA-PRP is produced by introducing an exogenous activator such as calcium and is thought to contain higher concentrations of growth factors and cytokines [22].”
Background
Metadata
- Authors
- Cavallo, C., Roffi, A., Grigolo, B., Mariani, E., Pratelli, L., Merli, G., Kon, E., Marcacci, M., & Filardo, G.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-7
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2510968112
- Cited by
- 317
- References
- 26
- FWCI
- 23.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.